Overview

Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations, in Healthy Volunteers

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of two formulations (tablets and granules for dispersion) of the antimalarial drug Pyramax (which is a combination of pyronaridine and artesunate).
Phase:
Phase 1
Details
Lead Sponsor:
Medicines for Malaria Venture
Collaborator:
Shin Poong Pharmaceutical Co. Ltd.
Treatments:
Artemisinins
Artesunate
Pyronaridine